Clinical trial ASTX660-01
Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas
| Cancers | |
|---|---|
| Organ | Lymphoma |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Astex Pharmaceuticals |
| EudraCT Identifier | 2016-005039-34 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT02503423 |
| Inclusion criteria | age >= 18 YOCTCL-PTCL>= 3th line |
| Last update |